Most Recent
Mayne Pharma is facing a new hurdle in its plans to merge with US drug maker Cosette, with the Treasurer flagging it may block the $672 million deal.
Nine has asked for more details of celebrity surgeon Dr Munjed Al Muderis' challenge to the dismissal of his defamation case against the broadcaster, and says 10 days is not enough to hear the appeal.
The federal government has flagged its intention to bring a strike-out application to narrow the group member definition in a class action by single women and same-sex couples who were denied Medicare rebates for IVF.
J&J-owned Janssen Pharmaceutica has sued Juno Pharmaceuticals, alleging the Australian off-patent drug maker is threatening to infringe its patent for a schizophrenia drug by seeking to list its own products on the PBS.
Mayne Pharma has won a dispute with US drug maker Cosette over the termination of a $672 million merger agreement, with a judge finding Mayne did not breach its continuous disclosure obligations by failing to disclose a letter from the US FDA sooner.
Construction PRO
Mutual company Australian Unity has sold the Greensborough Medical Centre and Day Hospital in Victoria to the Property Advisory for $32.5 million.
The Victorian Supreme Court has granted cosmetic surgeon Daniel Lanzer an extension to provide discovery in a class action against him and his clinic after hearing he was facing medical issues.
Blooms the Chemist can't overturn a decision from the Pharmacy Council of NSW blocking the registration of a chemist, with a judge finding there was no evidence Blooms would not have a financial interest in the business.
ASX-listed biotech 4D Medical has sued competitor Cyclopharm alleging the company made false, misleading and malicious statements about its rival during an online webinar prompted by a "fake" question.
Samsung Bioepis has successfully opposed Janssen's bid to patent a monoclonal antibody to treat ulcerative colitis, but an IP Australia delegate has given the J&J-owned company a chance to fix its application.